XBiotech Inc.
XBIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $4 | $18 |
| % Growth | – | -100% | -78.2% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $6 |
| Gross Profit | $0 | $0 | $3 | $13 |
| % Margin | – | – | 83.8% | 68.4% |
| R&D Expenses | $38 | $33 | $32 | $28 |
| G&A Expenses | $5 | $5 | $6 | $9 |
| SG&A Expenses | $5 | $5 | $6 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $42 | $38 | $38 | $38 |
| Operating Income | -$42 | -$38 | -$34 | -$25 |
| % Margin | – | – | -860.1% | -136.4% |
| Other Income/Exp. Net | $4 | $13 | $1 | -$0 |
| Pre-Tax Income | -$39 | -$24 | -$34 | -$25 |
| Tax Expense | -$0 | $0 | -$1 | -$8 |
| Net Income | -$39 | -$25 | -$33 | -$17 |
| % Margin | – | – | -820.4% | -94.7% |
| EPS | -1.26 | -0.81 | -1.08 | -0.58 |
| % Growth | -55.6% | 25% | -86.2% | – |
| EPS Diluted | -1.26 | -0.81 | -1.08 | -0.58 |
| Weighted Avg Shares Out | 30 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 30 | 30 | 30 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $10 | $4 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $3 | $3 |
| EBITDA | -$36 | -$23 | -$32 | -$22 |
| % Margin | – | – | -794.9% | -122% |